Informações:
Falhas:
ID
34700
Descrição
Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM); ODM derived from: https://clinicaltrials.gov/show/NCT01196546
Link
https://clinicaltrials.gov/show/NCT01196546
Palavras-chave
Versões (1)
- 23/01/2019 23/01/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
23 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes Mellitus NCT01196546
Eligibility Type 2 Diabetes Mellitus NCT01196546
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT01196546
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diabetes Mellitus, Non-Insulin-Dependent | Metformin U/day
Item
type 2 diabetes mellitus patients who are treated with metformin monotherapy 1,000 mg daily for at least 3 months
boolean
C0011860 (UMLS CUI [1])
C0025598 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0025598 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Hemoglobin A1c measurement
Item
the patient is required to have hba1c 6.5-11.0%
boolean
C0474680 (UMLS CUI [1])
Body mass index
Item
bmi in the range of 22-48 kg/m2
boolean
C1305855 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus Severe | Non-Insulin-Dependent Diabetes Mellitus Uncontrolled | Hemoglobin A1c measurement
Item
severe or uncontrolled type 2 diabetes mellitus (hba1c> 11.0%)
boolean
C0011860 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0474680 (UMLS CUI [3])
C0205082 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0474680 (UMLS CUI [3])
Complications of Diabetes Mellitus Metabolic | Ketoacidosis | Hyperosmolar state | Coma
Item
acute metabolic diabetes complications such as ketoacidosis or hyperosmolar state (coma) within the past 6 months
boolean
C0342257 (UMLS CUI [1,1])
C0311400 (UMLS CUI [1,2])
C0220982 (UMLS CUI [2])
C0236013 (UMLS CUI [3])
C0009421 (UMLS CUI [4])
C0311400 (UMLS CUI [1,2])
C0220982 (UMLS CUI [2])
C0236013 (UMLS CUI [3])
C0009421 (UMLS CUI [4])
Congestive heart failure Requirement Pharmacotherapy
Item
congestive heart failure requiring pharmacologic treatment
boolean
C0018802 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0013216 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,2])
C0013216 (UMLS CUI [1,3])
Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery | Percutaneous Coronary Intervention
Item
any of following within past 6 months: (1) myocardial infarction; (2) unstable angina (3) coronary artery bypass surgery or percutaneous coronary intervention
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0010055 (UMLS CUI [3])
C1532338 (UMLS CUI [4])
C0002965 (UMLS CUI [2])
C0010055 (UMLS CUI [3])
C1532338 (UMLS CUI [4])
Liver disease | Liver Cirrhosis | Hepatitis, Chronic
Item
liver disease such as cirrhosis or chronic active hepatitis
boolean
C0023895 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
C0019189 (UMLS CUI [3])
C0023890 (UMLS CUI [2])
C0019189 (UMLS CUI [3])